The ASPREE Healthy Ageing Biobank: Methodology and participant characteristics.
ASPirin in Reducing Events in the Elderly (ASPREE), a placebo-controlled prevention trial of low dose aspirin, provided the opportunity to establish a biospecimen biobank from initially healthy persons aged 70+ years for future research. The ASPREE Healthy Ageing Biobank (ASPREE Biobank) collected,...
Main Authors: | Emily J Parker, Suzanne G Orchard, Tom J Gilbert, James J Phung, Alice J Owen, Trevor Lockett, Mark R Nelson, Christopher M Reid, Andrew M Tonkin, Walter P Abhayaratna, Peter Gibbs, John J McNeil, Robyn L Woods |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0294743&type=printable |
Similar Items
-
Sleep apnoea, cognition and aspirin's effects in healthy older people: an ASPREE substudy
by: Stephanie A. Ward, et al.
Published: (2025-02-01) -
Occupational characteristics and disability-free survival after retirement age: an exploratory analysis from the ASPREE study
by: Sheikh M. Alif, et al.
Published: (2023-12-01) -
Socio-Demographic, Lifestyle, and Clinical Characteristics of Early and Later Weight Status in Older Adults: Secondary Analysis of the ASPREE Trial and ALSOP Sub-Study
by: Tagrid A. Alharbi, et al.
Published: (2023-06-01) -
Development of a standardized definition for clinically significant bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) trial
by: Karen L. Margolis, et al.
Published: (2018-09-01) -
Engaging GPs and primary care patients in research: Implications of the ASPREE trial for future studies
by: Sheppard, JP, et al.
Published: (2019)